A Hyperactive RelA/p65-Hexokinase 2 Signaling Axis Drives Primary Central Nervous System Lymphoma - Tateishi, Kensuke; Miyake, Yohei; Kawazu, Masahito; Sasaki, Nobuyoshi; Nakamura, Taishi; Sasame, Jo; Yoshii, Yukie; Ueno, Toshihide; Miyake, Akio; Watanabe, Jun; Matsushita, Yuko; Shiba, Norio; et al. (Cancer research (Chicago, Ill.), 2020)
Keywords: Animals; CD79 Antigens - genetics; Central Nervous System Neoplasms - drug therapy; Central Nervous System Neoplasms - metabolism; Central Nervous System Neoplasms - mortality; Central Nervous System Neoplasms - pathology; Female; Glycolysis; Hexokinase - genetics; Hexokinase - metabolism; Humans; Lymphoma - drug therapy; Lymphoma - metabolism; Lymphoma - mortality; Lymphoma - pathology; Mice, SCID; Mutation; Myeloid Differentiation Factor 88 - genetics; NF-kappa B - metabolism; NIMA-Interacting Peptidylprolyl Isomerase - metabolism; Signal Transduction; Transcription Factor RelA - metabolism; Viral Matrix Proteins - genetics; Viral Matrix Proteins - metabolism; Xenograft Model Antitumor Assays